Oncology
Global Lung Cancer Screening Software Market to 2032
Revenue, 2024 (USD Million)
47.30
Forecast, 2032 (USD Million)
227.10
CAGR, 2024 - 2032
25.46%
Report Coverage
Global
Global Lung Cancer Screening Software Market 2018-2032 USD Million
Global Lung Cancer Screening Software Market, Overview (2024-2032)
Market Growth and Projections:
- Market Size (2024): 47.30 USD Million
- Projected Market Size (2032): 227.10 USD Million
- CAGR (2024-2032): 25.46%
Key Findings of Global Lung Cancer Screening Software Market
- The Global Lung Cancer Screening Software Market is likely to grow at a CAGR of 25.46% during the forecast period of 2024 to 2032.
- Global Lung Cancer Screening Software Marketsize was valued at 47.30 USD Million in 2024.
- In 2024, Institutional segment dominated the market with the largest market share.
- Nodule Management Software in the product segment is expected to witness the fastest growth during the forecast period.
Global Lung Cancer Screening Software Market Scope
Global Lung Cancer Screening Software Market Segmentation & Scope
Distribution Channel
- Third Party Distributor
- Direct Tenders
End User
- Others
- Ambulatory Surgical Centers
- Hospitals
- Oncology Centers
Product
- Audit Log Tracking
- Practice Management
- Screening PACs
- Statistical Audit Reporting
- Pathology and Cancer Staging
- Lung Nodule Computer Aided Detection
- Patient Coordination and Workflow
- Data Collection and Reporting
- Nodule Management Software
- Lung Cancer Screening Patient Management Software
- Lung Cancer Screening Radiology Solution
Mode of Delivery
- Web Based Solutions1
- On-Premise Solutions1
- Cloud Based Solutions1
Application
- Small Cell Lung Cancer (SCLC)
- Non-Small Cell Lung Cancer (NSCLC)
Platform
- Integrated
- Standalone
Purchase Mode
- Individual
- Institutional
Type
- Traditional Screening
- Computer-Assisted Screening
Global Lung Cancer Screening Software Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2019 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 47.30 USD Million |
| Market Value in 2032 | 227.10 USD Million |
| CAGR (2024-2032) | 25.46% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Product,Mode of Delivery,Application,Platform,Purchase Mode,Type |
| Largest Segment | Institutional |
| Fastest Growing Segment | Nodule Management Software |
| Major Players | Medtronic, Oncocyte Corporation, Nuance Communications, Inc., Koninklijke Philips N.V., Thynk Health, Volpara Health Limited, Canon Medical Informatics, Inc., General Electric, Others, Siemens Healthcare GmbH |
Market Segmentation:
-
Product Segment:
- Largest Segment (2024): Institutional
- Fastest Growing Segment (2024-2032): Nodule Management Software
Regional Insights:
-
Leading Market (2024-2032): Global
- Key Country: U.S., leading in terms of revenue and market share by 2032.
Global Lung Cancer Screening Software Market Company Share Analysis
| Name | Market Share | OwnnerShip | HQ | Website |
|---|---|---|---|---|
| Medtronic | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Oncocyte Corporation | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Nuance Communications | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Koninklijke Philips N.V. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Thynk Health | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Volpara Health Limited | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Canon Medical Informatics | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| General Electric | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Others | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Siemens Healthcare GmbH | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
Global Lung Cancer Screening Software Market Geographical Sales Distribution, 2018-2032 USD Million
Global Lung Cancer Screening Software Market Company Profiling
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
Frequently Asked Questions
The Global Lung Cancer Screening Software Market is segmented based on Segmentation Distribution Channel,End User,Product,Mode of Delivery,Application,Platform,Purchase Mode,Type.
Global Lung Cancer Screening Software Market was valued at USD 47.30(Revenue in USD Million) in 2019.
Global Lung Cancer Screening Software Market is projected to grow at a CAGR of 25.46% during the forecast period of 2024 to 2032.
The estimated market value of the Global Lung Cancer Screening Software Market for final year is USD 227.10 (USD Million).
Related Markets
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.
